The most popular abortion method in the U.S. could vanish from the market, leaving providers scrambling to find alternatives after the end of Roe v. Wade.
A Texas judge is expected to rule soon on a case seeking to remove the Food and Drug Administration’s decades-old approval of mifepristone, one of two pills commonly used together to terminate a pregnancy. The anti-abortion group behind the suit is arguing the FDA fast-tracked the drug’s authorization and lacked sufficient evidence to make its final decision.
Research has shown that medication abortion is safe and effective. Mifepristone is approved for use in more than 80 countries, including Canada, Sweden and the U.K.
